Jeffrey Stein, Ph.D.

Dr. Stein has been President, CEO, and Director of Cidara since January 2014. Previously, he was the CEO of Trius Therapeutics, Inc., from 2007 until its acquisition by Cubist Pharmaceuticals, Inc., in September 2013. Dr. Stein currently serves as a Director of Paratek Pharmaceuticals (NASDAQ: PRTK) and Ideaya Biosciences (NASDAQ: IDYA). Dr. Stein conducted his postdoctoral research as an Alexander Hollaender Distinguished Postdoctoral Fellow at the California Institute of Technology and his graduate work as a NASA Graduate Student Researcher Fellow at the University of California, San Diego.